Home / Publications / Highlights of our experience in Lifesciences in O...

Highlights of our experience in Lifesciences in Oman

  • Zentiva NV on its acquisition of 75% of Eczacibasi Generic Pharmaceuticals in Turkiye for €460 million.
  • Ethemba Capital and NBGI Private Equity on the acquisition of a controlling stake in the Birgi Mefar Group in Turkiye for £20 million.

Please download the print version below.

microscope with bottles of chemicals in forefront
Brochures
Lifesciences
Download
PDF 158.6 kB